Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$ttiv Graphic](https://lunarcrush.com/gi/w:26/t:$ttiv.png) $ttiv

Thiogenesis is dosing patients in a Euro Phase X trial for TTI-0102. Interim efficacy readout expected this fall.

### About $ttiv
A biotechnology company focused on developing treatments for Leigh Syndrome and MELAS.  

### Engagements: XXX [#](/topic/$ttiv/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ttiv/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$ttiv/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXX +493%  
**1-Year High**: XXXXX on 2025-05-05  
**1-Year Low**: X on 2025-05-10  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$ttiv/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ttiv/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$ttiv/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: X -XX%  
**1 Month**: X +700%  
**1-Year High**: X on 2025-05-11  
**1-Year Low**: X on 2025-05-05  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$ttiv/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ttiv/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$ttiv/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $ttiv in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Week**: X no change  
**1 Month**: X +200%  
**1-Year High**: X on 2025-05-06  
**1-Year Low**: X on 2025-05-05  

**Top topics mentioned**
In the posts about $ttiv in the last XX hours

[$tti](/topic/$tti), [$ttipf](/topic/$ttipf), [lss](/topic/lss)

### Top Social Posts [#](/topic/$ttiv/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Estimated at $273M in 2025 & projected to hit $436M by 2032 the Leigh Syndrome treatment market is wide open. With no approved therapies @thiogenesis is dosing patients in a Euro Phase X trial for TTI-0102. More info 🔽 $TTI.v $TTIPF Market Source:"  
[@StckMasterFlash](/creator/x/StckMasterFlash) on [X](/post/tweet/1948840135644381650) 2025-07-25 20:17:50 UTC 2902 followers, XXX engagements


"In a market projected to grow to nearly half a billion dollars by 2035 @thiogenesis is dosing patients in its EU Phase X trial for TTI0102 targeting the underlying antioxidant deficiencies in MELAS. Interim efficacy readout expected this fall. More Info🔽 $TTI.v $TTIPF Source:"  
[@StckMasterFlash](/creator/x/StckMasterFlash) on [X](/post/tweet/1948127165847138686) 2025-07-23 21:04:45 UTC 2902 followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$ttiv Graphic $ttiv

Thiogenesis is dosing patients in a Euro Phase X trial for TTI-0102. Interim efficacy readout expected this fall.

About $ttiv

A biotechnology company focused on developing treatments for Leigh Syndrome and MELAS.

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Month: XXX +493%
1-Year High: XXXXX on 2025-05-05
1-Year Low: X on 2025-05-10

Social Network X
Engagements XXX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X -XX%
1 Month: X +700%
1-Year High: X on 2025-05-11
1-Year Low: X on 2025-05-05

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $ttiv in the last XX hours which is no change from in the previous XX hours Daily Average: X
1 Week: X no change
1 Month: X +200%
1-Year High: X on 2025-05-06
1-Year Low: X on 2025-05-05

Top topics mentioned In the posts about $ttiv in the last XX hours

$tti, $ttipf, lss

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Estimated at $273M in 2025 & projected to hit $436M by 2032 the Leigh Syndrome treatment market is wide open. With no approved therapies @thiogenesis is dosing patients in a Euro Phase X trial for TTI-0102. More info 🔽 $TTI.v $TTIPF Market Source:"
@StckMasterFlash on X 2025-07-25 20:17:50 UTC 2902 followers, XXX engagements

"In a market projected to grow to nearly half a billion dollars by 2035 @thiogenesis is dosing patients in its EU Phase X trial for TTI0102 targeting the underlying antioxidant deficiencies in MELAS. Interim efficacy readout expected this fall. More Info🔽 $TTI.v $TTIPF Source:"
@StckMasterFlash on X 2025-07-23 21:04:45 UTC 2902 followers, XX engagements

$ttiv
/topic/$ttiv